Singapore markets close in 3 hours 18 minutes

Galera Therapeutics, Inc. (GRTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.7000+0.0100 (+0.59%)
At close: 04:00PM EDT
1.7900 +0.09 (+5.29%)
After hours: 06:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 45.33M
Enterprise value -25.59M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)29.39
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.35

Trading information

Stock price history

Beta (5Y monthly) 2.32
52-week change 3-79.42%
S&P500 52-week change 3-5.66%
52-week high 310.7900
52-week low 31.1500
50-day moving average 32.0470
200-day moving average 33.8317

Share statistics

Avg vol (3-month) 3228.27k
Avg vol (10-day) 3195.29k
Shares outstanding 526.82M
Implied shares outstanding 6N/A
Float 817.64M
% held by insiders 15.52%
% held by institutions 146.21%
Shares short (28 Apr 2022) 4645.91k
Short ratio (28 Apr 2022) 44.61
Short % of float (28 Apr 2022) 42.77%
Short % of shares outstanding (28 Apr 2022) 42.41%
Shares short (prior month 30 Mar 2022) 4524.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-54.78%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -72.59M
Net income avi to common (ttm)-80.53M
Diluted EPS (ttm)-3.1230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)71.22M
Total cash per share (mrq)2.66
Total debt (mrq)302k
Total debt/equity (mrq)N/A
Current ratio (mrq)5.98
Book value per share (mrq)-2.19

Cash flow statement

Operating cash flow (ttm)-67.96M
Levered free cash flow (ttm)-44.7M